Your browser doesn't support javascript.
loading
Human monoclonal antibodies derived from a patient infected with 2009 pandemic influenza A virus broadly cross-neutralize group 1 influenza viruses.
Pan, Yang; Sasaki, Tadahiro; Kubota-Koketsu, Ritsuko; Inoue, Yuji; Yasugi, Mayo; Yamashita, Akifumi; Ramadhany, Ririn; Arai, Yasuha; Du, Anariwa; Boonsathorn, Naphatsawan; Ibrahim, Madiha S; Daidoji, Tomo; Nakaya, Takaaki; Ono, Ken-ichiro; Okuno, Yoshinobu; Ikuta, Kazuyoshi; Watanabe, Yohei.
Afiliación
  • Pan Y; Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
  • Sasaki T; Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan; JST/JICA, Science and Technology Research Partnership for Sustainable Development (SATREPS), Tokyo, Japan.
  • Kubota-Koketsu R; Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan; Kanonji Institute, The Research Foundation for Microbial Diseases of Osaka University, Kanonji, Kagawa, Japan; JST/JICA, Science and Technology Research Partnership for Sustainable Development (SATREPS), Tokyo, Japan.
  • Inoue Y; Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan; JST/JICA, Science and Technology Research Partnership for Sustainable Development (SATREPS), Tokyo, Japan.
  • Yasugi M; Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan; Graduate School of Life and Environmental Sciences, Osaka Prefecture University, Izumisano, Osaka, Japan; JST/JICA, Science and Technology Research Partnership for Sustainable Development (SATREPS), Tokyo, Japan.
  • Yamashita A; Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
  • Ramadhany R; Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
  • Arai Y; Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
  • Du A; Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan; JST/JICA, Science and Technology Research Partnership for Sustainable Development (SATREPS), Tokyo, Japan.
  • Boonsathorn N; Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan; Department of Medical Sciences, Ministry of Public Health, Muang, Nonthaburi, Thailand; JST/JICA, Science and Technology Research Partnership for Sustainable Development (SATREPS), Tokyo, Japan.
  • Ibrahim MS; Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan; Department of Microbiology and Immunology, Faculty of Veterinary Medicine, Damanhour University, Damanhour, Egypt.
  • Daidoji T; Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan; Department of Infectious Diseases, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto, Japan.
  • Nakaya T; Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan; Department of Infectious Diseases, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto, Japan; JST/JICA, Science and Technology Research Partnership for Sustainable Development (SATREPS), Tokyo, Japan.
  • Ono K; Ina Laboratory, Medical & Biological Laboratories Corporation, Ltd., Ina, Nagano, Japan; JST/JICA, Science and Technology Research Partnership for Sustainable Development (SATREPS), Tokyo, Japan.
  • Okuno Y; Kanonji Institute, The Research Foundation for Microbial Diseases of Osaka University, Kanonji, Kagawa, Japan.
  • Ikuta K; Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan; JST/JICA, Science and Technology Research Partnership for Sustainable Development (SATREPS), Tokyo, Japan. Electronic address: Ikuta@biken.osaka-u.ac.jp.
  • Watanabe Y; Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan; JST/JICA, Science and Technology Research Partnership for Sustainable Development (SATREPS), Tokyo, Japan. Electronic address: nabe@biken.osaka-u.ac.jp.
Biochem Biophys Res Commun ; 450(1): 42-8, 2014 Jul 18.
Article en En | MEDLINE | ID: mdl-24858683

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Virus de la Influenza A / Gripe Humana / Subtipo H1N1 del Virus de la Influenza A / Anticuerpos Neutralizantes / Hemaglutininas / Anticuerpos Monoclonales Límite: Animals / Humans Idioma: En Revista: Biochem Biophys Res Commun Año: 2014 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Virus de la Influenza A / Gripe Humana / Subtipo H1N1 del Virus de la Influenza A / Anticuerpos Neutralizantes / Hemaglutininas / Anticuerpos Monoclonales Límite: Animals / Humans Idioma: En Revista: Biochem Biophys Res Commun Año: 2014 Tipo del documento: Article País de afiliación: Japón